Inovio Pharmaceuticals
Utility Patents

Last updated:

List of all Inovio Pharmaceuticals patents 28 in total

Status Patent
Grant
Utility: Cancer vaccines targeting PRAME and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 24 May 2022
Grant
Utility: Cancer vaccines targeting LEMD1 and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 24 May 2022
Grant
Utility: Device and method for single-needle in vivo electroporation External link
Filling date: 7 Sep 2025 Issue date: 17 May 2022
Grant
Utility: Minimally invasive dermal electroporation device External link
Filling date: 7 Sep 2025 Issue date: 5 Apr 2022
Grant
Utility: Electroporation device having a battery pack with power switch External link
Filling date: 7 Sep 2025 Issue date: 5 Apr 2022
Grant
Utility: DNA antibody constructs and method of using same External link
Filling date: 7 Sep 2025 Issue date: 22 Mar 2022
Grant
Utility: Cancer vaccines targeting MUC16 and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 1 Feb 2022
Grant
Utility: DNA antibody constructs for use against middle east respiratory syndrome coronavirus External link
Filling date: 7 Sep 2025 Issue date: 25 Jan 2022
Grant
Utility: DNA antibody constructs and method of using same External link
Filling date: 7 Sep 2025 Issue date: 28 Dec 2021
Grant
Utility: Cancer vaccines targeting mesothelin and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 26 Oct 2021
Grant
Utility: Cancer vaccines targeting BORIS and uses thereof External link
Filling date: 7 Sep 2025 Issue date: 26 Oct 2021
Grant
Utility: MERS-CoV vaccine External link
Filling date: 7 Sep 2025 Issue date: 5 Oct 2021
Grant
Utility: Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom External link
Filling date: 7 Sep 2025 Issue date: 21 Sep 2021
Grant
Utility: Checkpoint inhibitor and vaccine combinations and use of same for immunotherapy External link
Filling date: 7 Sep 2025 Issue date: 14 Sep 2021
Grant
Utility: Filovirus consensus antigens, nucleic acid constructs and vaccines made therefrom, and methods of using same External link
Filling date: 7 Sep 2025 Issue date: 17 Aug 2021
Grant
Utility: Electroporation device with detachable needle array with lock-out system External link
Filling date: 7 Sep 2025 Issue date: 27 Jul 2021
Grant
Utility: Consensus prostate antigens, nucleic acid molecule encoding the same and vaccine and uses comprising the same External link
Filling date: 7 Sep 2025 Issue date: 29 Jun 2021
Grant
Utility: Intradermal jet injection electroporation device External link
Filling date: 7 Sep 2025 Issue date: 8 Jun 2021
Grant
Utility: Vaccines having an antigen and interleukin-21 as an adjuvant External link
Filling date: 7 Sep 2025 Issue date: 18 May 2021
Grant
Utility: Cancer vaccines and methods of treatment using the same External link
Filling date: 7 Sep 2025 Issue date: 18 May 2021
Grant
Utility: Vaccines with interleukin-33 as an adjuvant External link
Filling date: 7 Sep 2025 Issue date: 2 Mar 2021
Grant
Utility: Vaccines with CD40 ligand as an adjuvant External link
Filling date: 7 Sep 2025 Issue date: 23 Feb 2021
Grant
Utility: Vaccines for human papilloma virus and methods for using the same External link
Filling date: 7 Sep 2025 Issue date: 2 Feb 2021
Grant
Utility: Oral mucosal electroporation device and use thereof External link
Filling date: 7 Sep 2025 Issue date: 2 Feb 2021
Grant
Utility: PD1 and PDL1 antibodies and vaccine combinations and use of same for immunotherapy External link
Filling date: 7 Sep 2025 Issue date: 17 Nov 2020
Grant
Utility: Miniminally invasive dermal electroporation device External link
Filling date: 7 Sep 2025 Issue date: 2 Jun 2020
Grant
Utility: MERS-CoV vaccine External link
Filling date: 7 Sep 2025 Issue date: 4 Feb 2020
Grant
Utility: Influenza nucleic acid molecules and vaccines made therefrom External link
Filling date: 7 Sep 2025 Issue date: 3 Sep 2019

Showing 1 to 28 of 28 patents.